Buscar
-
Power shifts in the regulation of medicines: an inter-field analysis of a French agency
(Critical Policy Studies. vol. 12, n° 3, pp. 314-334, 2018)Article de revue -
Specific features of amoxicillin-associated DRESS: a nationwide study
(Journal of the European Academy of Dermatology and Venereology, 2021-08-30)Article de revue -
Spontaneous reporting of adverse-drug reactions as an outlet for patient dismay? The case of Levothyrox(R) change of excipients
(Fundamental and Clinical Pharmacology, 2022-01-06)Article de revue -
Association Between Antiangiogenic Drugs Used for Cancer Treatment and Artery Dissections or Aneurysms
(JAMA oncology, 2021-03-18)Article de revue -
Systematising Pharmacovigilance Engagement of Patients, Healthcare Professionals and Regulators: A Practical Decision Guide Derived from the International Risk Governance Framework for Engagement Events and Discourse
(Drug Safety. pp. 1193-1208, 2021-09-15)Article de revueLibre acceso -
JAK inhibitors and risk of major cardiovascular events or venous thromboembolism: a self-controlled case series study
(European Journal of Clinical Pharmacology. vol. 78, pp. 1981-1990, 2022-10-26)Article de revue -
A safety signal of somnambulism with the use of antipsychotics and lithium: A pharmacovigilance disproportionality analysis
(British Journal of Clinical Pharmacology, 2021-03-13)Article de revue -
Use of psychotropic drugs in the elderly in France: Are we condemned to remain at high tide?
(Therapies, 2023-03-15)Article de revue -
The ongoing structuring of human papillomavirus (HPV) vaccination in middle schools in Nouvelle-Aquitaine, France
(Infectious Diseases Now. vol. 53, n° 5, pp. 104717, 2023-05-04)Article de revue -
Systematic review on sex differences for drug use after stroke
(Fundamental and Clinical Pharmacology. vol. 36, pp. 111-111, 2022-06)Article de revue